Albert Kane

Albert J. Kane, DVM, MPVM, Ph.D.

ARTICLES

Research Journal: September/October 2019

The information, ideas and opinions expressed are those of the author and do not necessarily represent those of the United States Department of Agriculture.
Examination of a series of lameness cases in Texas revealed insights into why owners of 200 cutting horses sought treatment at the Texas A&M Veterinary Teaching Hospital. Two hundred cutting horses were presented for evaluation with poor performance being the more common complaint (58%) compared with lameness (42%). All of the horses were lame in at least one limb and 81/200 were lame in multiple limbs.
Read More

Research Journal: May/June 2019

The information, ideas and opinions expressed are those of the author and do not necessarily represent those of the United States Department of Agriculture.
Ontario Racehorse Deaths This descriptive study examined the frequency of racehorse deaths in Ontario, Canada, from 2003 through 2015. In 2003, the Ontario Racing Commission created a reporting system to record all deaths of Thoroughbred, Quarter Horse and Standardbred racehorses that occurred within 60 days of racing or entering a race or timed work. Owners are required to report all deaths that occur regardless of the cause or where the death occurred.
Read More

Research Journal: April 2019

The information, ideas and opinions expressed are those of the author and do not necessarily represent those of the United States Department of Agriculture.
Computer Tomography for Removal of Keratomas Clinicians at the University of California, Davis veterinary teaching hospital described the use of computer tomography (CT) for the diagnosis and presurgical planning of treatment for hoof wall keratomas in 29 horses and three mules from 2005 through 2016.
Read More

Research Journal: March 2019

The information, ideas and opinions expressed are those of the author and do not necessarily represent those of the United States Department of Agriculture.
Regional Tiludronate for Navicular Syndrome Tiludronate is a bisphosphonate medication used to prevent the loss of bone density by decreasing the activity of osteoclasts, cells that cause bone resorption when active.
Read More

Top Articles

Current Issue

View More

Current Issue

View More

Must Read Free Eguides

Download these helpful knowledge building tools

View More
Top Directory Listings